DCPH - Deciphera Pharmaceuticals Inc
IEX Last Trade
12.94
0.120 0.927%
Share volume: 346,158
Last Updated: Tue 08 Aug 2023 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$12.82
0.12
0.94%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-04 | 2022-08-04 | 2022-11-03 | 2023-02-07 | 2023-05-03 | 2023-08-09 | 2023-10-30 | |
| Total revenue | 29.223 M | 32.494 M | 35.974 M | 36.345 M | 33.445 M | 38.304 M | 43.313 M | |
| Cost of revenue | 382.000 K | 1.799 M | 3.344 M | 3.245 M | 488.000 K | 173.000 K | 1.286 M | |
| Gross profit | 28.841 M | 30.695 M | 32.630 M | 33.100 M | 32.957 M | 38.131 M | 42.027 M | |
| 6.43% | 6.30% | 1.44% | -0.43% | 15.70% | 10.22% | |||
| Operating expenses | 75.733 M | 74.483 M | 77.511 M | 80.261 M | 86.214 M | 90.906 M | 95.715 M | |
| Selling general and admin | 28.321 M | 29.625 M | 30.026 M | 32.195 M | 31.449 M | 32.610 M | 33.252 M | |
| Research and development | 47.412 M | 44.858 M | 47.485 M | 48.066 M | 54.765 M | 58.296 M | 62.463 M | |
| Total expenses | 76.115 M | 76.282 M | 80.855 M | 83.506 M | 86.702 M | 91.079 M | 97.001 M | |
| 0.22% | 5.99% | 3.28% | 3.83% | 5.05% | 6.50% | |||
| Operating income | -46.892 M | -43.788 M | -44.881 M | -47.161 M | -53.257 M | -52.775 M | -53.688 M | |
| Ebit | -46.892 M | -43.788 M | -44.881 M | -47.161 M | -53.257 M | -52.775 M | -53.688 M | |
| Pretax income | -46.892 M | -43.061 M | -43.043 M | -45.213 M | -49.609 M | -48.562 M | -49.581 M | |
| -8.17% | -0.04% | 5.04% | 9.72% | -2.11% | 2.10% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 722.000 K | 0.000 | 0.000 | 0.000 | |
| Net income basic | -46.892 M | -43.061 M | -43.043 M | -45.935 M | -49.609 M | -48.562 M | -49.581 M | |
| 8.17% | 0.04% | -6.72% | -8.00% | 2.11% | -2.10% | |||
| Net income | -46.892 M | -43.061 M | -43.043 M | -45.935 M | -49.609 M | -48.562 M | -49.581 M | |
| 8.17% | 0.04% | -6.72% | -8.00% | 2.11% | -2.10% |